SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Trickle Portfolio -- Ignore unavailable to you. Want to Upgrade?


To: tuck who wrote (331)1/5/2001 12:01:03 PM
From: scaram(o)uche  Read Replies (3) | Respond to of 1784
 
Talking about Argonaut..... next time Voodoo or TD are in the library, could one of you check the affiliations for all authors on this manuscript? TIA!!!

(p.s. is there a way to get affiliations of secondary authors via Medline/PubMed??..... I run into this issue all the time, and have never found a "fix")

Bioorg Med Chem Lett 1999 Jan 18;9(2):209-12
Parallel synthesis of 1,2,4-oxadiazoles using CDI activation.

Deegan TL, Nitz TJ, Cebzanov D, Pufko DE, Porco JA Jr

Argonaut Technologies, San Carlos, CA 94070, USA.

1,2,4-Oxadiazoles have been prepared in parallel using 1,1'-carbonyldiimidazole (CDI) as a reagent for both formation and cyclodehydration of O-acyl benzamidoximes. The use of CDI facilitates parallel purification of the oxadiazole products by simple liquid-liquid extraction and filtration.